UK markets closed

Boston Scientific Corporation (BSX)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
55.26+0.31 (+0.56%)
At close: 04:00PM EST
55.26 0.00 (0.00%)
After hours: 04:54PM EST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
1,228,000
698,000
1,041,000
-140,000
4,700,000
Depreciation & amortisation
1,177,000
1,136,000
1,093,000
1,123,000
1,011,000
Deferred income taxes
-67,000
-63,000
-124,000
-82,000
-4,301,000
Stock-based compensation
229,000
220,000
194,000
170,000
157,000
Change in working capital
-379,000
-1,005,000
-351,000
42,000
-282,000
Accounts receivable
-208,000
-220,000
-279,000
335,000
-130,000
Inventory
-647,000
-321,000
-346,000
-65,000
-290,000
Accounts payable
430,000
-255,000
408,000
-
-
Other working capital
1,615,000
914,000
1,316,000
1,132,000
1,375,000
Other non-cash items
82,000
191,000
-52,000
170,000
66,000
Net cash provided by operating activities
2,353,000
1,526,000
1,870,000
1,508,000
1,836,000
Cash flows from investing activities
Investments in property, plant and equipment
-738,000
-612,000
-554,000
-376,000
-461,000
Acquisitions, net
-1,018,000
-1,542,000
-2,258,000
-3,000
-4,382,000
Purchases of investments
-
-
-
-146,000
-348,000
Sales/maturities of investments
2,000
56,000
294,000
-
-
Other investing activities
-
-
-1,000
87,000
1,000
Net cash used for investing activities
-1,704,000
-2,011,000
-1,597,000
-411,000
-5,041,000
Cash flows from financing activities
Debt repayment
-4,000
-3,435,000
0
-6,843,000
-4,560,000
Common stock issued
-
0
0
975,000
123,000
Common stock repurchased
-
0
0
-535,000
-
Dividends paid
-41,000
-55,000
-55,000
-28,000
-
Other financing activities
-90,000
-411,000
-100,000
-147,000
121,000
Net cash used provided by (used for) financing activities
-8,000
-547,000
-95,000
294,000
2,973,000
Net change in cash
636,000
-1,042,000
173,000
1,388,000
-222,000
Cash at beginning of period
497,000
2,168,000
1,995,000
607,000
829,000
Cash at end of period
1,137,000
1,126,000
2,168,000
1,995,000
607,000
Free cash flow
Operating cash flow
2,353,000
1,526,000
1,870,000
1,508,000
1,836,000
Capital expenditure
-738,000
-612,000
-554,000
-376,000
-461,000
Free cash flow
1,615,000
914,000
1,316,000
1,132,000
1,375,000